Loading stock data…
AngioDynamics, Inc. (ANGO)
$15.20-0.27 (-1.75%)
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
AngioDynamics, Inc. in the Healthcare sector is trading at $15.20 with a market capitalization of $627M. Wall Street consensus targets $20.00 (4 analysts), implying a +31.6% move over the next 12 months. The stock is currently near its 52-week high of $16.29, remaining 24.3% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +31.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $86.61M↑ | $78.42M↓ | $79.43M↑ | $75.71M↓ | $80.16M |
| Gross Profit | $46.77M↑ | $41.48M↓ | $44.78M↑ | $41.86M↓ | $42.22M |
| Operating Income | -$5.51M↑ | -$6.43M↓ | -$2.49M↑ | -$7.90M↓ | -$3.63M |
| Net Income | -$11.40M↓ | -$8.08M↓ | -$6.35M↑ | -$10.90M↓ | -$6.05M |
Peer Comparison
JNJUNHPFE
Fundamentals
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Devi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$627.01M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.32
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-21.51%
Volume
Today's trading volume
527,438
Recent News
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?
AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027
AngioDynamics (NASDAQ:ANGO) expects its MedTech business to become the majority of company revenue in fiscal 2027, as the company continues a multiyear shift away from slower-growth legacy markets and toward higher-growth medical technology platforms, executives said during a Canaccord fireside chat
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus
AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs, spending and losses pressure margins.
ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?
AngioDynamics' 33.5% three-month rally rests on Med Tech growth, but valuation, tariffs and negative earnings keep execution risks high.